Moxifloxacin Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2025-10-29 · last update 2025-10-29
Manufacturers: Fresenius Kabi USA, LLC
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Moxifloxacin, Injection, 400mg per 250mL (NDC 63323-850-74) | Fresenius Kabi USA, LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 10/29/2025 Updated 10/29/2025 Discontinued 10/29/2025 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)